ReWalk Robotics Ltd. (NASDAQ: RWLK) was established in 2001 and is headquartered in Yokneam Ilit, Israel. It has 65 full-time employees. It is a medical device company mainly engaged in the design, development and sales of wearable exoskeleton system products for lower limb disabilities The patient’s dynamic hip and knee movements.
ReWalk Robotics (RWLK):
ReWalk Robotics is an Israeli company listed on the Nasdaq. The company develops an exoskeleton device that helps paralyzed people walk, bringing new hope to people who have lost leg mobility. ReWalk allows users to walk independently and control their own pace, just like people with normal limbs. Through computers and motion sensors, ReWalk can control movement by detecting subtle changes in the position of the center of gravity, imitating natural steps, and providing users with a suitable walking speed, enabling quadriplegics to walk independently. Users can even run a marathon, and a paralyzed woman did it in 2012.
Rewalk has two versions: rewalk I and rewalk P. The former is used in medical institutions for research or treatment and should be supervised by medical professionals, while the latter is a version that patients can use by themselves. At present, the latest version of rewalk 2.0 was launched in January 2013, which can improve the size to allow taller people to use, and strengthen the control software.
ReWalk Robotics products have passed the US ” Food and Drug Administration FDA ” and EU CE certification in 2014. This system has been tested for a long time in Israel, the United States and Europe. Some people involved in the ReWalk test phase project have already started using the device. Clinical studies have shown that in addition to providing the wearer with the ability to stand and walk independently, as the user gains a more positive self-image in the process of gaining independence and being able to control his own actions, ReWalk can also bring the user’s mental health. Comes great benefits.
In addition, research also shows that ReWalk can improve cardiovascular health, reduce fat tissue, strengthen muscles, and improve bowel function. Rewalk users said that since using the system, their pain has been reduced, the amount of medication used has been reduced, and the number of hospital visits has also been reduced.
ReWalk Robotics products are mainly suitable for patients with spinal cord injury, stroke, cerebral palsy, and multiple sclerosis. With the improvement of living standards, the number of stroke patients has greatly increased, and the use of cars, as well as the number of people with spinal cord injuries and lower limb injuries, is on the rise. Therefore, the company’s products have good commercial prospects in the future.
ReWalk Robotics (RWLK) investment:
ReWalk Robotics was IPO on Nasdaq in September 2014 with an issue price of US$12 per share. Since its listing, it has been strongly sought after by funds. In the first month, it rose by 264% to US$43.71, becoming one of the monster stocks of the month. However, since the second month, it has been in a state of adjustment until it is now closed below $1 per share.